RYAH Group, a leading digital health care analytics and technology company, is set to benefit with a commitment to advancing the world’s transition to remote-health solutions and data analytics in patient treatments. A recent Becker’s Hospital Review article cites 10 emerging trends in health IT that will shape the field in 2021, reporting that big data management is increasingly necessary with the blossoming use of artificial intelligence (“AI”) and machine learning in health care (https://cnw.fm/hK7J3). RYAH is set to be at the forefront of the information-driven future as a company committed to leveraging the value of health devices combined with data to positively impact the treatment of patients with various medical conditions. A recent article discussing this reads, “RYAH aggregates data collected by its product ecosystem, creating a HIPAA-compliant database enhanced by AI-powered solutions designed to analyze and clarify complex relationships between peer-reviewed research, consumer feedback and therapeutic plants. As the company specializing in unlocking data in the complete therapeutic plant lifecycle — from seed to consumption — RYAH appears strategically placed in the $100.3 billion medical plant market, with the potential to capitalize on growth opportunities enabled by both the IoT and data intelligence.”
To view the full article, visit https://cnw.fm/m4p22
RYAH Group Inc.
RYAH Group is a leader in digital health care analytics and technology. By creating a suite of dose-measuring, IoT devices that capture data from seed to consumption, RYAH is positioned to unearth breakthrough discoveries capable of reshaping the understanding of plant-based medicine. For more information, visit the company’s website at https://www.RYAHGroup.com.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
